Opthea Ltd has released a press release.
Opthea Investor Day
Filed with ASX ·
On 6ix: 6ix.com/news/opthea-investor-day
6ix hasn’t read this filing yet.
In the deck
Earlier from Opthea
- Opthea's Corporate Presentation - Jan 2025
- Opthea Announces Publication in Diabetic Macular Edema
- Opthea's Wet AMD Program to be Featured at FLORetina 2024
- Opthea Received A$15.9 Million R&D Tax Incentive
- Chair's Address to Shareholders
Later from Opthea
- Opthea Completes COAST Final Week 52 Patient Visit
- Opthea Completes Drug Product PPQ Campaign
- Opthea Half Year Financial Report - Appendix 4D
- Opthea Reports Half Year Results and Business Updates
- Opthea Announces Phase 2b Wet AMD Publication
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea